Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Federal Trade Commission
Merck
Fuji
Julphar
Accenture
Medtronic
Baxter
Boehringer Ingelheim

Generated: October 19, 2018

DrugPatentWatch Database Preview

Teva Parenteral Company Profile

« Back to Dashboard

What is the competitive landscape for TEVA PARENTERAL, and what generic and branded alternatives to TEVA PARENTERAL drugs are available?

TEVA PARENTERAL has forty-seven approved drugs.

There are six tentative approvals on TEVA PARENTERAL drugs.

Summary for Teva Parenteral
US Patents:0
Tradenames:39
Ingredients:37
NDAs:47
Patent Litigation for Teva Parenteral: See patent lawsuits for Teva Parenteral

Drugs and US Patents for Teva Parenteral

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Parenteral CYTARABINE cytarabine INJECTABLE;INJECTION 016793-004 Dec 21, 1987 DISCN Yes No ➤ Sign Up ➤ Sign Up
Teva Parenteral ERYTHROMYCIN LACTOBIONATE erythromycin lactobionate INJECTABLE;INJECTION 063253-001 Jul 30, 1993 DISCN No No ➤ Sign Up ➤ Sign Up
Teva Parenteral CLINDAMYCIN PHOSPHATE clindamycin phosphate INJECTABLE;INJECTION 063282-001 May 29, 1992 DISCN No No ➤ Sign Up ➤ Sign Up
Teva Parenteral DEXAMETHASONE SODIUM PHOSPHATE dexamethasone sodium phosphate INJECTABLE;INJECTION 081126-001 Aug 31, 1990 DISCN No No ➤ Sign Up ➤ Sign Up
Teva Parenteral ACYCLOVIR SODIUM acyclovir sodium INJECTABLE;INJECTION 074969-001 Aug 26, 1997 DISCN No No ➤ Sign Up ➤ Sign Up
Teva Parenteral NEOSAR cyclophosphamide INJECTABLE;INJECTION 040015-004 Apr 29, 1993 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Expired US Patents for Teva Parenteral

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Teva Parenteral CYTARABINE cytarabine INJECTABLE;INJECTION 016793-001 Approved Prior to Jan 1, 1982 3,444,294 ➤ Sign Up
Teva Parenteral CYTARABINE cytarabine INJECTABLE;INJECTION 016793-002 Approved Prior to Jan 1, 1982 3,444,294 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Express Scripts
Julphar
AstraZeneca
Medtronic
Cantor Fitzgerald
QuintilesIMS
US Army
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.